Literature DB >> 9872677

Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock.

O Bloom1, H Wang, S Ivanova, J M Vishnubhakat, M Ombrellino, K J Tracey.   

Abstract

Experimental models of lethal endotoxemia in rodents are widely used to delineate pathogenic mechanisms of inflammation, sepsis, and septic shock. One long-standing but poorly understood observation is that removal of the pituitary gland (hypophysectomy) renders experimental animals 1,000-fold more sensitive to the lethal sequelae of lipopolysaccharide (LPS). Previous explanations for this phenomenon focused on hypophysectomy-induced deficiencies of corticosteroids, because glucocorticoids effectively suppress the synthesis of tumor necrosis factor (TNF), which is a primary mediator of LPS lethality. We measured LPS-stimulated macrophage TNF release in the presence of serum from hypophysectomized rats to detect the appearance of an inducible 65 kDa protein that enhances TNF release. Surprisingly, the N-terminal amino acid sequence analysis of the isolated, purified protein revealed its identity as hemoglobin. Hypophysectomy significantly increases serum hemoglobin levels (control hemoglobin = 103+/-18 microg/mL versus hypophysectomized serum hemoglobin = 279+/-13 microg/mL; p < .05). Purified hemoglobin enhances TNF synthesis in LPS-stimulated macrophages by at least 1,000-fold, which is specifically inhibited by antihemoglobin antibodies. Thus, hemoglobin mediates increased TNF synthesis in endotoxemic, hypophysectomized rats. This mechanism of increased TNF release has potential implications for patients with hemoglobinemia following blood transfusion, surgery, injury, infection, or other conditions that can be associated with endotoxemia and sepsis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872677     DOI: 10.1097/00024382-199812000-00003

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Authors:  Huan Yang; Haichao Wang; Yaakov A Levine; Manoj K Gunasekaran; Yongjun Wang; Meghan Addorisio; Shu Zhu; Wei Li; Jianhua Li; Dominique Pv de Kleijn; Peder S Olofsson; H Shaw Warren; Mingzhu He; Yousef Al-Abed; Jesse Roth; Daniel J Antoine; Sangeeta S Chavan; Ulf Andersson; Kevin J Tracey
Journal:  JCI Insight       Date:  2016-05-19

3.  Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome.

Authors:  Michael Adamzik; Tim Hamburger; Frank Petrat; Jürgen Peters; Herbert de Groot; Matthias Hartmann
Journal:  Crit Care       Date:  2012-07-16       Impact factor: 9.097

Review 4.  [Role of the innate immune response in sepsis].

Authors:  C Hörner; A Bouchon; A Bierhaus; P P Nawroth; E Martin; H J Bardenheuer; M A Weigand
Journal:  Anaesthesist       Date:  2004-01       Impact factor: 1.041

5.  Lipopolysaccharide-induced hemolysis: Evidence for direct membrane interactions.

Authors:  Stephan Brauckmann; Katharina Effenberger-Neidnicht; Herbert de Groot; Michael Nagel; Christian Mayer; Jürgen Peters; Matthias Hartmann
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

6.  High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis.

Authors:  David Cucchiari; Enric Reverter; Miquel Blasco; Alicia Molina-Andujar; Adriá Carpio; Miquel Sanz; Angels Escorsell; Javier Fernández; Esteban Poch
Journal:  BMC Nephrol       Date:  2018-10-04       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.